2nd Quarter - Report
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug and Medical Device Pedigree, H.R. 5839; DMEPOS and Lab Competitive Bidding, H.R. 6331; Physician Payments Sunshine Act, S. 2029
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON FRAZIER | Government Affairs Analyst |
| ADNAN JALIL | Government Affairs Director |
| AMY MICHAEL KOHL | Government Affairs Analyst |
| MATTHEW JAMES ROWAN | President and CEO |
| ANDREW VAN OSTRAND | Vice President, Policy and Research |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.